Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer
- 31 March 1993
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 9 (1) , 221-228
- https://doi.org/10.1016/0169-5002(93)90674-m
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Induction chemotherapy for non-small cell carcinoma of the lung: limitations and lessonsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1991
- The rationale for continuous, hyperfractionated, accelerated radiotherapy (chart)International Journal of Radiation Oncology*Biology*Physics, 1990
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Primary tumor control after radiotherapy for carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1983